Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. September 2023 08:00 ET | Quelle: VantAI

VantAI Announces Formation of Scientific Advisory Board

NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- VantAI, a leading company focused on the application of artificial intelligence to drug discovery, today announced its newly formed Scientific Advisory...
27. Juli 2023 08:00 ET | Quelle: VantAI

Geometric Deep Learning Pioneer Michael Bronstein joins VantAI as Chief Scientist in Residence to Help Drive Artificial Intelligence Breakthroughs in Drug Discovery

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- VantAI, a leader in ML technologies for drug discovery, is excited to announce the appointment of Dr. Michael Bronstein as Chief Scientist in Residence....
20. April 2022 07:00 ET | Quelle: VantAI

VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders

VantAI will pair its induced proximity platform with BI’s deep early discovery experience to identify targeted protein degraders with enhanced properties for traditionally “undruggable” targets NEW...
13. April 2022 07:00 ET | Quelle: VantAI

VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen

NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- VantAI, an AI-first induced-proximity company, today announced it has entered into a multi-year collaboration agreement with Janssen Pharmaceutica NV,...